Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 13901-13950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT07032077
A Phase II Clinical Trial on the Safety, Tolerability, and Efficacy of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors.
PHASE2Recruiting
100 participants
Started: Jul 9, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT07055113
Adapting Rehabilitation Delivery for Maximum Impact at Home-2 (ReDI-2)
NARecruiting
270 participants
Started: Jul 9, 2025 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT07042945
MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)
PHASE1Recruiting
28 participants
Started: Jul 9, 2025 · Completed: Apr 6, 2026
1 condition1 sponsor2 locations
NCT07047638
A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine
NARecruiting
171 participants
Started: Jul 9, 2025 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT06914726
Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes
NAEnrolling by invitation
2,488 participants
Started: Jul 9, 2025 · Completed: Mar 31, 2029
5 conditions2 sponsors1 location
NCT06244472
A New Generation of Magnetoencephalographs for High Speed Functional Brain Imaging
NARecruiting
80 participants
Started: Jul 9, 2025 · Completed: Aug 31, 2027
2 conditions1 sponsor2 locations
NCT07065916
Arm More + Camp: An Implementation Study
NAEnrolling by invitation
18 participants
Started: Jul 9, 2025 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06915025
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
PHASE3Recruiting
500 participants
Started: Jul 9, 2025 · Completed: Oct 31, 2032
4 conditions1 sponsor4 locations
NCT06927999
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
PHASE2Recruiting
42 participants
Started: Jul 9, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT07202728
A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)
N/ARecruiting
1,489 participants
Started: Jul 9, 2025 · Completed: Aug 30, 2030
1 condition14 sponsors14 locations
NCT06002763
Evaluation of Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 for Postpartum Women
N/ARecruiting
200 participants
Started: Jul 9, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06892288
A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG
PHASE2/PHASE3Recruiting
50 participants
Started: Jul 9, 2025 · Completed: Aug 31, 2026
2 conditions1 sponsor16 locations
NCT06642220
Ablative Radioembolization of Renal Cell Carcinoma Trial
PHASE2Recruiting
16 participants
Started: Jul 9, 2025 · Completed: Dec 31, 2032
2 conditions2 sponsors1 location
NCT05391672
Augmentation of Partial Anterior Cruciate Ligament Tear: Early Results
NARecruiting
30 participants
Started: Jul 9, 2025 · Completed: Mar 19, 2026
2 conditions1 sponsor1 location
NCT07059624
Femoral Arterial Cannulation in Pediatrics
NARecruiting
80 participants
Started: Jul 9, 2025 · Completed: Jan 1, 2027
3 conditions1 sponsor1 location
NCT06923618
Cancer of the Lung And SeneScencE - Prospective Cohort 1
NARecruiting
385 participants
Started: Jul 9, 2025 · Completed: Jul 31, 2032
1 condition1 sponsor1 location
NCT07043972
Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
PHASE2Recruiting
55 participants
Started: Jul 9, 2025 · Completed: Jan 1, 2031
1 condition1 sponsor2 locations
NCT06661564
Identification of Diagnosis Biomarkers in the Tears of Alzheimer's Disease Patients: The COG-EYE Pilot Study
NARecruiting
90 participants
Started: Jul 9, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06722521
GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification
PHASE4Recruiting
7,435 participants
Started: Jul 9, 2025 · Completed: Oct 31, 2032
2 conditions1 sponsor1 location
NCT07029919
Personalized Approach To Habits - Sleep
NANot yet recruiting
120 participants
Started: Jul 9, 2025 · Completed: Aug 15, 2025
6 conditions2 sponsors0 locations
NCT06841133
Chinese Art Activities or Combined With Peer Group Participation on Psychological Well Being
NANot yet recruiting
90 participants
Started: Jul 9, 2025 · Completed: Aug 9, 2025
1 condition1 sponsor3 locations
NCT06834633
Nephroprotection in Severe Trauma Patients With Kidney Stress
NARecruiting
523 participants
Started: Jul 9, 2025 · Completed: Sep 30, 2027
1 condition1 sponsor6 locations
NCT06490770
Analysis of the Pathophysiological and Functional State of the Knee Joint
NARecruiting
25 participants
Started: Jul 9, 2025 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT07057648
Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea
N/ANot yet recruiting
100 participants
Started: Jul 9, 2025 · Completed: May 31, 2027
5 conditions1 sponsor1 location
NCT06678841
ELEVATE-HFpEF Clinical Study
NARecruiting
700 participants
Started: Jul 9, 2025 · Completed: Feb 28, 2029
1 condition1 sponsor5 locations
NCT06986421
Perception of Advanced Rehabilitation Technologies Among Post-Stroke Patients and Rehabilitation Staff
N/ARecruiting
80 participants
Started: Jul 8, 2025 · Completed: Jul 8, 2026
1 condition1 sponsor1 location
NCT06885697
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
PHASE1Recruiting
100 participants
Started: Jul 8, 2025 · Completed: Jun 1, 2044
8 conditions1 sponsor1 location
NCT07028515
Self-controlled Practice on Motor Learning and Motivation in Parkinson's Disease
N/ARecruiting
72 participants
Started: Jul 8, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT07070791
Combined Upper Extremity Resistance and Aerobic Exercise Training in Patients With Breast Cancer
NARecruiting
40 participants
Started: Jul 8, 2025 · Completed: May 1, 2026
4 conditions1 sponsor1 location
NCT06915194
SMART Pilot Trial of Glycemic Screening Outreach
NAEnrolling by invitation
105 participants
Started: Jul 8, 2025 · Completed: Nov 8, 2025
2 conditions1 sponsor1 location
NCT07015957
Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention
PHASE4Active, not recruiting
7,000 participants
Started: Jul 8, 2025 · Completed: Aug 31, 2029
1 condition4 sponsors1 location
NCT07159581
Gene Therapy for Wilson Disease Evaluated by 64Cu PET/CT
N/AEnrolling by invitation
5 participants
Started: Jul 8, 2025 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT06845514
Impact of Resistance Training Intensity on Blood Pressure
NARecruiting
36 participants
Started: Jul 8, 2025 · Completed: Dec 31, 2028
4 conditions1 sponsor1 location
NCT06799234
Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)
PHASE2Recruiting
240 participants
Started: Jul 8, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06692686
AFO Prescription to Optimize Post-Stroke Function
NARecruiting
120 participants
Started: Jul 8, 2025 · Completed: Oct 31, 2027
3 conditions5 sponsors4 locations
NCT06709469
Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults
PHASE1Recruiting
10 participants
Started: Jul 8, 2025 · Completed: Dec 1, 2030
1 condition1 sponsor1 location
NCT05930496
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors
NARecruiting
30 participants
Started: Jul 8, 2025 · Completed: Jul 1, 2027
3 conditions2 sponsors1 location
NCT07017023
Combined Blood Pressure Medication and Activity Scheduling for Low Mood
EARLY_PHASE1Recruiting
76 participants
Started: Jul 8, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06893965
Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
NARecruiting
100 participants
Started: Jul 8, 2025 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT07059793
MITRIS China Post Market Clinical Follow-up (PMCF) Study
N/ARecruiting
250 participants
Started: Jul 8, 2025 · Completed: Dec 31, 2038
1 condition4 sponsors7 locations
NCT07090889
Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome.
PHASE1Recruiting
64 participants
Started: Jul 8, 2025 · Completed: Feb 11, 2026
1 condition1 sponsor1 location
NCT06950177
Pancoronavirus Vaccine Study in Healthy Adults
PHASE1Recruiting
51 participants
Started: Jul 8, 2025 · Completed: Aug 30, 2026
3 conditions2 sponsors1 location
NCT07019571
tDCS and Urge in BFRBs
NARecruiting
55 participants
Started: Jul 8, 2025 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT07030010
Effect of a Liquid Tonic Drink on Post-meal Glucose and Insulin Responses
NARecruiting
20 participants
Started: Jul 8, 2025 · Completed: Dec 19, 2025
1 condition1 sponsor1 location
NCT07069309
A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Adults, Including Those at Higher Risk of Severe COVID-19
PHASE3Recruiting
100 participants
Started: Jul 8, 2025 · Completed: Jan 6, 2026
2 conditions2 sponsors6 locations
NCT06970665
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
PHASE4Recruiting
20 participants
Started: Jul 8, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor12 locations
NCT07076407
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
PHASE3Recruiting
450 participants
Started: Jul 8, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor16 locations
NCT07219875
Training Reward Responsiveness Through Virtual Reality
PHASE2Recruiting
80 participants
Started: Jul 8, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT06992882
A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS)
PHASE3Recruiting
2,306 participants
Started: Jul 8, 2025 · Completed: Jun 10, 2030
1 condition1 sponsor1 location
NCT06529159
H. Pylori Eradication With Argon Plasma During Endoscopy
NARecruiting
20 participants
Started: Jul 8, 2025 · Completed: Dec 1, 2026
5 conditions2 sponsors1 location